SCHEMBL7664310

SCHEMBL7664310

CCCCn1cnc2c(OCC)nc(Nc3cnc4ccccc4c3)nc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 8/20 0.42
▸ CCNE1 P24864 6/20 0.42
▸ PDGFRA P16234 5/20 0.42
▸ IGF1R P08069 7/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TRPV1 Q8NER1 2/20 0.38
▸ CCNE2 O96020 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ CTSL P07711 1/20 0.38
▸ EGFR P00533 2/20 0.37
▸ INSR P06213 2/20 0.37
▸ MET P08581 2/20 0.37
▸ KDR P35968 2/20 0.37
▸ TEK Q02763 2/20 0.37
▸ TMIGD3 P0DMS9 1/20 0.37
▸ ADORA2A P29274 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7666193 0.93 CDK2 (0.41) CDK2CCNE1PDGFRAIGF1RRAB9A
SCHEMBL7666399 0.91 CDK2 (0.40) CDK2CCNE1PDGFRAIGF1RKMT2A
SCHEMBL7670174 0.91 CDK2 (0.40) CDK2CCNE1PDGFRAIGF1RRAB9A
SCHEMBL7666197 0.91 CDK2 (0.40) CDK2CCNE1PDGFRAIGF1RRAB9A
SCHEMBL7672070 0.90 CDK2 (0.41) CDK2CCNE1PDGFRAIGF1RRAB9A
SCHEMBL7668416 0.89 CCNE1 (0.41) CDK2CCNE1PDGFRAIGF1RRAB9A
SCHEMBL7672349 0.89 SLC29A1 (0.43) CDK2CCNE1PDGFRAIGF1RRAB9A
SCHEMBL7668634 0.86 CCNE1 (0.54) CDK2CCNE1PDGFRACCNE2CTSL
SCHEMBL7668440 0.83 CCNE1 (0.51) CDK2CCNE1PDGFRACCNE2TMIGD3
SCHEMBL7666287 0.82 PDGFRA (0.41) CDK2CCNE1PDGFRATSHRCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 — — US claimed
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 — — US disclosed
Send feedback